Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1986;79(Suppl 12):55–63.

An overview of the management of cystic fibrosis.

J M Littlewood
PMCID: PMC1290129  PMID: 3522917

Full text

PDF
55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggett P. J., Cavanagh N. P., Matthew D. J., Pincott J. R., Sutcliffe J., Harries J. T. Shwachman's syndrome. A review of 21 cases. Arch Dis Child. 1980 May;55(5):331–347. doi: 10.1136/adc.55.5.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Auerbach H. S., Williams M., Kirkpatrick J. A., Colten H. R. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet. 1985 Sep 28;2(8457):686–688. doi: 10.1016/s0140-6736(85)92929-0. [DOI] [PubMed] [Google Scholar]
  3. Beaudry P. H., Marks M. I., McDougall D., Desmond K., Rangel R. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? J Pediatr. 1980 Jul;97(1):144–147. doi: 10.1016/s0022-3476(80)80155-7. [DOI] [PubMed] [Google Scholar]
  4. Bonin A., Roy C. C., Lasalle R., Weber A., Morin C. L. Fecal chymotrypsin: a reliable index of exocrine pancreatic function in children. J Pediatr. 1973 Oct;83(4):594–600. doi: 10.1016/s0022-3476(73)80220-3. [DOI] [PubMed] [Google Scholar]
  5. Brown J. Efficacy of antimicrobial drugs against staphylococci in cystic fibrosis. Aust Paediatr J. 1980 Sep;16(3):207–209. doi: 10.1111/j.1440-1754.1980.tb01299.x. [DOI] [PubMed] [Google Scholar]
  6. Brown R. C., Chalmers D. M., Rowe V. L., Kelleher J., Littlewood J. M., Losowsky M. S. Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis. J Clin Pathol. 1982 May;35(5):547–549. doi: 10.1136/jcp.35.5.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carter E. P., Barrett A. D., Heeley A. F., Kuzemko J. A. Improved sweat test method for the diagnosis of cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):919–922. doi: 10.1136/adc.59.10.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chalmers D. M., Brown R. C., Miller M. G., Clarke P. C., Kelleher J., Littlewood J. M., Losowsky M. S. The influence of long-term cimetidine as an adjuvant to pancreatic enzyme therapy in cystic fibrosis. Acta Paediatr Scand. 1985 Jan;74(1):114–117. doi: 10.1111/j.1651-2227.1985.tb10930.x. [DOI] [PubMed] [Google Scholar]
  9. Congden P. J., Bruce G., Rothburn M. M., Clarke P. C., Littlewood J. M., Kelleher J., Losowsky M. S. Vitamin status in treated patients with cystic fibrosis. Arch Dis Child. 1981 Sep;56(9):708–714. doi: 10.1136/adc.56.9.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Conway S. P., Miller M. G., Ramsden C., Littlewood J. M. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. Acta Paediatr Scand. 1985 Jan;74(1):107–113. doi: 10.1111/j.1651-2227.1985.tb10929.x. [DOI] [PubMed] [Google Scholar]
  11. Dandona P., Hodson M., Bell J., Ramdial L., Beldon I., Batten J. C. Serum immunoreactive trypsin in cystic fibrosis. Thorax. 1981 Jan;36(1):60–62. doi: 10.1136/thx.36.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. David T. J., Phillips B. M. Overdiagnosis of cystic fibrosis. Lancet. 1982 Nov 27;2(8309):1204–1206. doi: 10.1016/s0140-6736(82)91213-2. [DOI] [PubMed] [Google Scholar]
  13. Elias E., Muller D. P., Scott J. Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E. Lancet. 1981 Dec 12;2(8259):1319–1321. doi: 10.1016/s0140-6736(81)91342-8. [DOI] [PubMed] [Google Scholar]
  14. GIBSON L. E., COOKE R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed] [Google Scholar]
  15. Gow R., Bradbear R., Francis P., Shepherd R. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet. 1981 Nov 14;2(8255):1071–1074. doi: 10.1016/s0140-6736(81)91276-9. [DOI] [PubMed] [Google Scholar]
  16. Green A., Dodds P., Pennock C. A study of sweat sodium and chloride; criteria for the diagnosis of cystic fibrosis. Ann Clin Biochem. 1985 Mar;22(Pt 2):171–174. doi: 10.1177/000456328502200212. [DOI] [PubMed] [Google Scholar]
  17. Hadorn B., Johansen P. G., Anderson C. M. Pancreozymin secretin test of exocrine pancreatic funtion in cystic fribrosis and the significance of the result for the pathogenesis of the disease. Can Med Assoc J. 1968 Feb 24;98(8):377–385. [PMC free article] [PubMed] [Google Scholar]
  18. Heeley A. F., Heeley M. E., King D. N., Kuzemko J. A., Walsh M. P. Screening for cystic fibrosis by died blood spot trypsin assay. Arch Dis Child. 1982 Jan;57(1):18–21. [PMC free article] [PubMed] [Google Scholar]
  19. Henderson M. J., Littlewood J. M., Miller M. Interpretation of sweat sodium and chloride concentrations. Ann Clin Biochem. 1986 Jan;23(Pt 1):109–109. doi: 10.1177/000456328602300116. [DOI] [PubMed] [Google Scholar]
  20. Hodson M. E., Beldon I., Power R., Duncan F. R., Bamber M., Batten J. C. Sweat tests to diagnose cystic fibrosis in adults. Br Med J (Clin Res Ed) 1983 Apr 30;286(6375):1381–1383. doi: 10.1136/bmj.286.6375.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hodson M. E., Penketh A. R., Batten J. C. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet. 1981 Nov 21;2(8256):1137–1139. doi: 10.1016/s0140-6736(81)90588-2. [DOI] [PubMed] [Google Scholar]
  22. Hoiby N., Flensborg E. W., Beck B., Friis B., Jacobsen S. V., Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis. 1977 Apr;58(2):65–79. [PubMed] [Google Scholar]
  23. Holzer F. J., Olinsky A., Phelan P. D. Variability of airways hyper-reactivity and allergy in cystic fibrosis. Arch Dis Child. 1981 Jun;56(6):455–459. doi: 10.1136/adc.56.6.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hyatt A. C., Chipps B. E., Kumor K. M., Mellits E. D., Lietman P. S., Rosenstein B. J. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr. 1981 Aug;99(2):307–314. doi: 10.1016/s0022-3476(81)80486-6. [DOI] [PubMed] [Google Scholar]
  25. Jusko W. J., Mosovich L. L., Gerbracht L. M., Mattar M. E., Yaffe S. J. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics. 1975 Dec;56(6):1038–1044. [PubMed] [Google Scholar]
  26. Kun P., Landau L. I., Phelan P. D. Nebulized gentamicin in children and adolescents with cystic fibrosis. Aust Paediatr J. 1984 Mar;20(1):43–45. doi: 10.1111/j.1440-1754.1984.tb00035.x. [DOI] [PubMed] [Google Scholar]
  27. LOBECK C. C., MCSHERRY N. R. Response of sweat electrolyte concentrations to 9 alpha--fluorohydrocortisone in patients with cystic fibrosis and their families. J Pediatr. 1963 Mar;62:393–398. doi: 10.1016/s0022-3476(63)80136-5. [DOI] [PubMed] [Google Scholar]
  28. Lambert H. P. Clinical significance of tissue penetration of antibiotics in the respiratory tract. Scand J Infect Dis Suppl. 1978;(14):262–266. [PubMed] [Google Scholar]
  29. Loening-Baucke V. A., Mischler E., Myers M. G. A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis. J Pediatr. 1979 Oct;95(4):630–637. doi: 10.1016/s0022-3476(79)80785-4. [DOI] [PubMed] [Google Scholar]
  30. Mearns M. B. Treatment and prevention of pulmonary complications of cystic fibrosis in infancy and early childhood. Arch Dis Child. 1972 Feb;47(251):5–11. doi: 10.1136/adc.47.251.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Miller M. G., Ghoneim A. T., Littlewood J. M. Use of enoxacin in a patient with cystic fibrosis. Lancet. 1985 Mar 16;1(8429):646–646. doi: 10.1016/s0140-6736(85)92192-0. [DOI] [PubMed] [Google Scholar]
  32. Phelan P. D., Allan J. L., Landau L. I., Barnes G. L. Improved survival of patients with cystic fibrosis. Med J Aust. 1979 Apr 7;1(7):261–263. doi: 10.5694/j.1326-5377.1979.tb112071.x. [DOI] [PubMed] [Google Scholar]
  33. Phelan P., Hey E. Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80. Arch Dis Child. 1984 Jan;59(1):71–73. doi: 10.1136/adc.59.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Robinson M. J., Norman A. P. Life tables for cystic fibrosis. Arch Dis Child. 1975 Dec;50(12):962–965. doi: 10.1136/adc.50.12.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shmerling D. H., Forrer J. C., Prader A. Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion. Pediatrics. 1970 Nov;46(5):690–695. [PubMed] [Google Scholar]
  36. Shwachman H., Redmond A., Khaw K. T. Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics. 1970 Sep;46(3):335–343. [PubMed] [Google Scholar]
  37. Stead R. J., Redington A. N., Hinks L. J., Clayton B. E., Hodson M. E., Batten J. C. Selenium deficiency and possible increased risk of carcinoma in adults with cystic fibrosis. Lancet. 1985 Oct 19;2(8460):862–863. doi: 10.1016/s0140-6736(85)90127-8. [DOI] [PubMed] [Google Scholar]
  38. Stern R. C., Boat T. F., Doershuk C. F., Tucker A. S., Primiano F. P., Jr, Matthews L. W. Course of cystic fibrosis in 95 patients. J Pediatr. 1976 Sep;89(3):406–411. doi: 10.1016/s0022-3476(76)80537-9. [DOI] [PubMed] [Google Scholar]
  39. Szaff M., Høiby N., Flensborg E. W. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983 Sep;72(5):651–657. doi: 10.1111/j.1651-2227.1983.tb09789.x. [DOI] [PubMed] [Google Scholar]
  40. Wientzen R., Prestidge C. B., Kramer R. I., McCracken G. H., Nelson J. D. Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy. Am J Dis Child. 1980 Dec;134(12):1134–1138. doi: 10.1001/archpedi.1980.02130240018007. [DOI] [PubMed] [Google Scholar]
  41. Wilcken B., Brown A. R., Urwin R., Brown D. A. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants. J Pediatr. 1983 Mar;102(3):383–387. doi: 10.1016/s0022-3476(83)80653-2. [DOI] [PubMed] [Google Scholar]
  42. Wilmott R. W., Tyson S. L., Dinwiddie R., Matthew D. J. Survival rates in cystic fibrosis. Arch Dis Child. 1983 Oct;58(10):835–836. doi: 10.1136/adc.58.10.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wilson-Sharp R. C., Irving H. C., Brown R. C., Chalmers D. M., Littlewood J. M. Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):923–926. doi: 10.1136/adc.59.10.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wong L. T., Turtle S., Davidson A. G. Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis. Gut. 1982 Sep;23(9):744–750. doi: 10.1136/gut.23.9.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yeh T. F., Luken J. A., Thalji A., Raval D., Carr I., Pildes R. S. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study. J Pediatr. 1981 Jan;98(1):137–145. doi: 10.1016/s0022-3476(81)80560-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES